Walleye Capital’s Kailera Therapeutics KLRA Stock Holding History
Bought
Maintained
Sold
Other funds holding KLRA
Walleye Capital's KLRA Position: Q3 2026 in Review
Walleye Capital opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 416,853 shares worth $4.76M. The stake represents ﹤0.01% of the portfolio and ranks #1945 among its holdings.
129 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.
- Walleye Capital held 416,853 shares of Kailera Therapeutics worth $4.76M as of Q3 2026.
- Kailera Therapeutics was a new Walleye Capital position in Q3 2026.
- Kailera Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #1945 holding.
- 129 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.